Etanercept

Psoriatic Arthritis Improved With Etanercept Therapy

Psoriatic Arthritis Improved With Etanercept Therapy

By

Etanercept therapy reduces clinical markers of disease activity in patients with psoriatic arthritis while stabilizing cardiovascular disease risk factors over a period of 5 years.

Etanercept Associated With Lower Infection Than Monoclonal Antibodies

Etanercept Associated With Lower Infection Than Monoclonal Antibodies

For patients with rheumatoid arthritis, etanercept is associated with lower risk for general infections and tuberculosis compared with monoclonal antibody treatment,

Sign Up for Free e-Newsletters